ICD-10 Code C83.57 | Lymphoblastic (diffuse) lymphoma, spleen Symptoms, Diagnosis, Billing

Lymphoblastic (diffuse) lymphoma affecting the spleen is a type of aggressive non-Hodgkin lymphoma characterized by the proliferation of immature lymphoid cells. This condition is clinically significant due to its rapid progression and potential for systemic involvement. Accurate coding with ICD-10 Code C83.57 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this serious condition.

What is ICD-10 Code C83.57 for Lymphoblastic (diffuse) lymphoma, spleen?

ICD-10 Code C83.57 represents Lymphoblastic (diffuse) lymphoma localized to the spleen. This aggressive lymphoma is characterized by the presence of immature lymphocytes and can lead to splenomegaly and systemic symptoms. This code should be used in clinical documentation and billing when diagnosing patients with this specific type of lymphoma, ensuring accurate representation of the patient's condition for treatment and reimbursement purposes.

ICD-10 Code C83.57 – Clinical Definition and Explanation of Lymphoblastic (diffuse) lymphoma, spleen

Lymphoblastic (diffuse) lymphoma, spleen is a hematological malignancy that arises from immature lymphoid cells, often presenting with significant splenic involvement. The condition requires prompt medical attention due to its aggressive nature and potential for rapid progression. Early diagnosis and treatment are critical for improving patient outcomes.

Key Clinical Features:

• Commonly presents with splenomegaly and abdominal discomfort.
• May be associated with fever, night sweats, and weight loss.
• Typically affects adolescents and young adults.
• Can lead to leukemic transformation if untreated.

ICD-10 Code C83.57 for Lymphoblastic (diffuse) lymphoma, spleen – SOAP Notes & Clinical Use

In SOAP notes, ICD-10 Code C83.57 is utilized to document the diagnosis of Lymphoblastic (diffuse) lymphoma affecting the spleen. This code aids in capturing the patient's symptoms, assessment findings, and treatment plans, ensuring comprehensive documentation in both acute and chronic care settings.

What Does ICD-10 Code C83.57 for Lymphoblastic (diffuse) lymphoma, spleen Mean in SOAP Notes?

ICD-10 Code C83.57 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Lymphoblastic (diffuse) lymphoma, spleen. This code is crucial for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C83.57 – Lymphoblastic (diffuse) lymphoma, spleen

Lymphoblastic (diffuse) lymphoma, spleen requires urgent medical intervention, often necessitating hospitalization for intensive treatment.

Antibiotic Therapy:

• Not applicable as this is not an infectious condition.

Supportive Care:

• Chemotherapy regimens such as CHOP or hyper-CVAD.
• Supportive transfusions for anemia or thrombocytopenia.
• Management of symptoms such as pain and fever.

Infection Control:

• Implement standard precautions to prevent infection.
• Monitor for signs of febrile neutropenia during treatment.

How to Document Symptoms of Lymphoblastic (diffuse) lymphoma, spleen (ICD-10 C83.57) in SOAP Notes

Subjective:

• Patient reports abdominal pain and fullness.
• Experiencing night sweats and unintentional weight loss.
• History of fatigue and generalized weakness.

Objective:

• Physical exam reveals splenomegaly.
• CBC shows leukocytosis with immature lymphocytes.
• Imaging studies confirm splenic enlargement.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Lymphoblastic (diffuse) lymphoma, spleen (ICD-10 Code C83.57)

Assessment:

• Diagnosis of Lymphoblastic (diffuse) lymphoma, spleen, classified as aggressive.
• ICD-10 Code C83.57 applied for billing and documentation.
• Contributing factors include age and presenting symptoms.

Plan:

• Initiate chemotherapy with a regimen appropriate for lymphoblastic lymphoma.
• Educate patient on potential side effects and the importance of follow-up.
• Schedule regular monitoring of blood counts and response to treatment.

Treatment & Plan Section for ICD-10 Code C83.57 – Lymphoblastic (diffuse) lymphoma, spleen

• First-line treatment includes multi-agent chemotherapy.
• Non-pharmacologic strategies involve nutritional support and psychosocial counseling.
• Monitoring includes regular CBCs and imaging to assess treatment response.
• Follow-up appointments should be scheduled every 1-3 months during treatment.

Using ICD-10 Code C83.57 for Lymphoblastic (diffuse) lymphoma, spleen in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and clinical findings in SOAP notes.
• Use C83.57 in settings where lymphoblastic lymphoma is diagnosed or treated.
• Align treatment plans with clinical guidelines to support justified billing.
• Include relevant CPT codes that correspond to the services provided.

Related ICD-10 Codes Often Used with Lymphoblastic (diffuse) lymphoma, spleen

• C83.50 – Lymphoblastic lymphoma, unspecified site
• C83.51 – Lymphoblastic lymphoma, lymph nodes

ICD-10 Code C83.57 in Medical Billing and Insurance for Lymphoblastic (diffuse) lymphoma, spleen

ICD-10 Code C83.57 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings.

Billing Notes:

• Document all relevant clinical findings to support the use of C83.57.
• Use this code in inpatient and outpatient settings where treatment is provided.
• Ensure that all chart elements align with the diagnosis for accurate claims processing.

Common CPT Pairings: